Company profile
Cellexus - single-use airlift bioreactors
We pioneer revolutionary, market leading single-use airlift bioreactors. Our technology is designed to improve cell culture & fermentation processes.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQ0MDMyOTE3N2FkaXF6a2N4
Published 21 Oct 2024 04:45
PSC04 | Transaction MzQzMzQ2NDE1MmFkaXF6a2N4
Published 27 Aug 2024 12:37
PSC07 | Transaction MzQzMzQ2NDAxNWFkaXF6a2N4
Published 27 Aug 2024 12:36
Company registered at Companies House
1 Jun 2025 to 31 May 2026
This project pioneers a sustainable and cruelty-free approach to leather production by integrating cutting-edge biotechnology, advanced cell culture techniques, and scalable manufacturing processes. Traditional leather manufacturing relies heavily on cattle ranching, contributing to significant environmental challenges such as greenhouse gas emissions, de...
1 Jun 2021 to 30 Nov 2022
Cellexus was founded by Gavin Hands, Yann Lecouturier and Brian Wales. Cellexus is developing a novel airlift single-use bioreactor (SUB) dedicated to stem-cell production at a scale of 1--100 litres. It is expected to generate a year-5 post-project revenue of £26M. This system would have the potential to positively impact regenerative medicine, drug scre...
